One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

Life4me+ launches a web-version of the mobile app for the patient - picture 1

Life4me+ launches a web-version of the mobile app for the patient

27 April 2018, 08:25 contact@life4me.plus

From now on, all users of the mobile app Life4me+ have access to the "Personal account" function on the web-version. Now not only a specialist (a doctor or a social worker) can create a personal profile on the life4me.plus website - everyone who wants to, after simple registration, gets full access to the data available in the mobile version. Functionality of the "Personal account" is absolutely identical to that used in the mobile app.

The patient's Web-account contains the same tabs: "Tests", "PrEP", "Calendar", "Drugs" and "Journal".

The user, just as in the mobile app, can enter data, view the dynamics of the analyzes, track his own adherence to therapy, monitor their stock of drugs, etc.

In addition, a person who is on antiretroviral therapy or PrEP can set up reminder about taking medication, but, unlike a mobile app, the web-version of notification to the patient will not happen.

In the case of simultaneous use of the mobile and web-version all the indicators are fully synchronized.

Now anyone can start using the Life4me+ app, without first installing it on the smartphone. To do this, it is enough to just process the standard registration on the site life4me.plus - "For the patient".

Later, if the user decides to start working with the mobile version, he will only need to download the app. All previously entered data will be fully transferred to the application from the web-version.

Author: Alex Schneider


Latest News

All news - picture 2

Chemsex is associated with an increased risk of HIV transmission and sexual infections

The use of gay, bisexual and other men who have sex with men (#MSM), crystallized methamphetamine, mephedrone, γ-hydroxybutyrate or γ-butyrolactone, and to a lesser extent cocaine and ketamine during sexual intercourse, or the so-called " the phenomenon is relatively new, ...

23 May 15:48

All news - picture 3

ART drug Juluca appears in European pharmacies

Pharmaceutical company ViiV Healthcare, specializing in the development and production of medicines for HIV treatment, reported that the European Commission issued a permit for the implementation in Europe of the combined drug Juluca (#dolutegravir 50 mg / rilpivirine 25 ...

22 May 14:30

All news - picture 4

Truvada in the US will be used to reduce the risk of HIV transmission among adolescents

Gilead Sciences, Inc. announced that the FDA approved once-daily oral emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (Truvada) in combination with safe sex practices, to reduce the risk of sexually acquired HIV-1 in at-risk adolescents.

17 May 15:01

All news - picture 5

A patient has died from AIDS in Switzerland because he was not paid for HIV treatment

As it became known to the media, an HIV-positive patient died from AIDS in Switzerland in the end of 2017. He was being refused of a medical treatment due to missing necessary health insurance, and the insurance company refused several times to pay for the treatment because ...

1 May 14:29